Glutathione-s-transferase-pi expression in early breast cancer: Association with outcome and response to chemotherapy

Banu K. Arun, Laura A. Granville, Guosheng Yin, Lavinia P. Middleton, Shaheenah Dawood, Shu Wan Kau, Arif Kamal, Limin Hsu, Gabriel N. Hortobagyi, Aysegul A. Sahin

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Glutathione-S-transferase-pi (GST-pi) is a detoxification enzyme expressed in breast cancer; however its involvement in chemotherapy sensitivity and prognosis is not well understood. We evaluated the expression of GSTpi and its predictive role of chemotherapy response. Breast tumor samples from 166 patients at stage I/II of the disease were immunostained for GST-pi, and the expression was 96 . There was a trend toward improved disease-free survival with high GST-pi expression (p =.09). There was a statistically non-significant association between high GST-pi expression and improved outcome with adjuvant chemotherapy (p= .055). Further studies should evaluate the role of GST-pi expression in relation to response to different chemotherapies.

Original languageEnglish (US)
Pages (from-to)554-559
Number of pages6
JournalCancer Investigation
Volume28
Issue number5
DOIs
StatePublished - May 2010

Keywords

  • Breast cancer
  • Chemotherapy
  • Lutathione-S-transferase-pi
  • Prognosis and response predictions

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

MD Anderson CCSG core facilities

  • Biostatistics Resource Group

Fingerprint

Dive into the research topics of 'Glutathione-s-transferase-pi expression in early breast cancer: Association with outcome and response to chemotherapy'. Together they form a unique fingerprint.

Cite this